BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: French SW, Nash J, Shitabata P, Kachi K, Hara C, Chedid A, Mendenhall CL. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis. 1993;13:154-169. [PMID: 8393214 DOI: 10.1055/s-2007-1007346] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Osna NA, Feng D, Ganesan M, Maillacheruvu PF, Orlicky DJ, French SW, Tuma DJ, Kharbanda KK. Prolonged feeding with guanidinoacetate, a methyl group consumer, exacerbates ethanol-induced liver injury. World J Gastroenterol 2016; 22(38): 8497-8508 [PMID: 27784962 DOI: 10.3748/wjg.v22.i38.8497] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Robin M, Descatoire V, Pessayre D, Berson A. Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation. Toxicology in Vitro 2008;22:1511-9. [DOI: 10.1016/j.tiv.2008.05.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
3 Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011;2011:345803. [PMID: 21197451 DOI: 10.1155/2011/345803] [Cited by in Crossref: 151] [Cited by in F6Publishing: 165] [Article Influence: 12.6] [Reference Citation Analysis]
4 French SW, Mayer RJ, Bardag-gorce F, Ingelman-sundberg M, Rouach H, Neve E, Higashitsuji H. The Ubiquitin-Proteasome 26s Pathway in Liver Cell Protein Turnover: Effect of Ethanol and Drugs. Alcoholism Clin Exp Res 2001;25:225S-9S. [DOI: 10.1111/j.1530-0277.2001.tb02400.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
5 Murohisa G, Kobayashi Y, Kawasaki T, Nakamura S, Nakamura H. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver. 2002;22:394-403. [PMID: 12390475 DOI: 10.1034/j.1600-0676.2002.01552.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
6 French SW. Alcoholic hepatitis. Alcohol 2002;27:43-6. [DOI: 10.1016/s0741-8329(02)00205-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kharbanda KK, Todero SL, Thomes PG, Orlicky DJ, Osna NA, French SW, Tuma DJ. Increased methylation demand exacerbates ethanol-induced liver injury. Exp Mol Pathol. 2014;97:49-56. [PMID: 24842317 DOI: 10.1016/j.yexmp.2014.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 M. Brunt E, G. Tiniakos D. Fatty Liver Disease. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1087-114. [DOI: 10.1016/b978-141604059-0.50044-8] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]
9 French SW. Ethanol and Hepatocellular Injury. Clinics in Laboratory Medicine 1996;16:289-306. [DOI: 10.1016/s0272-2712(18)30270-1] [Cited by in Crossref: 17] [Article Influence: 0.7] [Reference Citation Analysis]
10 Lu JG, Ji P, French SW. The Major Histocompatibility Complex Class II-CD4 Immunologic Synapse in Alcoholic Hepatitis and Autoimmune Liver Pathology: The Role of Aberrant Major Histocompatibility Complex Class II in Hepatocytes. Am J Pathol 2020;190:25-32. [PMID: 31669415 DOI: 10.1016/j.ajpath.2019.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Brunt EM, Neuschwander-tetri BA, Burt AD. Fatty liver disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 293-359. [DOI: 10.1016/b978-0-7020-3398-8.00006-4] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
12 Lalor PF, Herbert J, Bicknell R, Adams DH. Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment. Am J Physiol Gastrointest Liver Physiol. 2013;304:G469-G478. [PMID: 23257923 DOI: 10.1152/ajpgi.00407.2012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
13 French SW, Enbom ET. Piecemeal necrosis of the liver revisited a review. Exp Mol Pathol 2014;96:307-9. [PMID: 24704429 DOI: 10.1016/j.yexmp.2014.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Bardag-gorce F, Riley NE, Nan L, Montgomery RO, Li J, French BA, Lue YH, French SW. The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. Experimental and Molecular Pathology 2004;76:9-16. [DOI: 10.1016/j.yexmp.2003.08.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
15 Méndez-sánchez N, Almeda-valdés P, Uribe M. Alcoholic liver disease. An update. Annals of Hepatology 2005;4:32-42. [DOI: 10.1016/s1665-2681(19)32083-6] [Cited by in Crossref: 21] [Article Influence: 1.2] [Reference Citation Analysis]
16 Che XH, Park EJ, Zhao YZ, Kim WH, Sohn DH. Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells. Basic Clin Pharmacol Toxicol 2010;106:30-7. [PMID: 19906051 DOI: 10.1111/j.1742-7843.2009.00465.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhuge J, Cederbaum AI. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1. Free Radic Biol Med 2006;41:1100-12. [PMID: 16962935 DOI: 10.1016/j.freeradbiomed.2006.06.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
18 Khouri ST, Perez RM, de Oliveira PM, Figueiredo VM, Barbosa DV, Lanzoni VP, Silva AE, Ferraz ML. Rebiopsy in patients with untreated hepatitis C: a useful procedure. J Clin Gastroenterol 2006;40:347-52. [PMID: 16633108 DOI: 10.1097/01.mcg.0000210100.36500.3f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Nanji AA, Khwaja S, Sadrzadeh SMH. Eicosanoid production in experimental alcoholic liver disease is related to vitamin E levels and lipid peroxidation. Mol Cell Biochem 1994;140:85-9. [DOI: 10.1007/bf00928370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Tung BY, Carithers RL Jr. Cholestasis and alcoholic liver disease. Clin Liver Dis 1999;3:585-601. [PMID: 11291240 DOI: 10.1016/s1089-3261(05)70086-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Villanueva JA, Esfandiari F, White ME, Devaraj S, French SW, Halsted CH. S-adenosylmethionine attenuates oxidative liver injury in micropigs fed ethanol with a folate-deficient diet. Alcohol Clin Exp Res. 2007;31:1934-1943. [PMID: 17850216 DOI: 10.1111/j.1530-0277.2007.00511.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
22 Mandel L, Hamele-Bena D. Alcoholic parotid sialadenosis. J Am Dent Assoc 1997;128:1411-5. [PMID: 9332142 DOI: 10.14219/jada.archive.1997.0060] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
23 Assy N, Jacob G, Spira G, Edoute Y. Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol 1999; 5(3): 252-262 [PMID: 11819442 DOI: 10.3748/wjg.v5.i3.252] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
24 Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol. 2000;32:689-702. [PMID: 10782920 DOI: 10.1016/s0168-8278(00)80233-0] [Cited by in Crossref: 139] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
25 Maher JJ. Leukocytes as Modulators of Stellate Cell Activation. Alcoholism Clin Exp Res 1999;23:917-21. [DOI: 10.1111/j.1530-0277.1999.tb04203.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
26 Zatloukal K, Stumptner C, Lehner M, Denk H, Baribault H, Eshkind LG, Franke WW. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000;156:1263-74. [PMID: 10751352 DOI: 10.1016/S0002-9440(10)64997-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
27 Le MD, Enbom E, Traum PK, Medici V, Halsted CH, French SW. Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies. Exp Mol Pathol 2013;95:187-91. [PMID: 23886644 DOI: 10.1016/j.yexmp.2013.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
28 Reilly ME, Mantle D, Salisbury J, Peters TJ, Preedy VR. Comparative effects of acute ethanol dosage on liver and muscle protein metabolism. Biochem Pharmacol 2000;60:1773-85. [PMID: 11108792 DOI: 10.1016/s0006-2952(00)00504-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 French SW, Bardag-gorce F. Ubiquitin-Proteasome Pathway in the Pathogenesis of Liver Disease. In: Dufour J, Clavien P, Trautwein C, Graf R, editors. Signaling Pathways in Liver Diseases. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 377-89. [DOI: 10.1007/3-540-27194-5_32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Esfandiari F, Medici V, Wong DH, Jose S, Dolatshahi M, Quinlivan E, Dayal S, Lentz SR, Tsukamoto H, Zhang YH. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology. 2010;51:932-941. [PMID: 19957376 DOI: 10.1002/hep.23382] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
31 Liu Y. HISTOPATHOLOGY OF ALCOHOLIC LIVER DISEASE. Clinics in Liver Disease 1998;2:753-63. [DOI: 10.1016/s1089-3261(05)70040-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
32 Lackner C, Gogg-kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis. Journal of Hepatology 2008;48:821-8. [DOI: 10.1016/j.jhep.2008.01.026] [Cited by in Crossref: 164] [Cited by in F6Publishing: 138] [Article Influence: 11.7] [Reference Citation Analysis]
33 French SW, Lee J, Zhong J, Morgan TR, Buslon V, Lungo W, French BA. Alcoholic liver disease - Hepatocellular carcinoma transformation. J Gastrointest Oncol 2012;3:174-81. [PMID: 22943009 DOI: 10.3978/j.issn.2078-6891.2012.025] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
34 Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol 2020;40:151-68. [PMID: 31389060 DOI: 10.1002/jat.3880] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
35 Maddrey WC. Alcohol-induced liver disease. Clin Liver Dis. 2000;4:115-131, vii. [PMID: 11232180 DOI: 10.1016/s1089-3261(05)70099-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
36 French S. The Pathophysiology of Alcoholic Liver Disease ∗. Liver Pathophysiology. Elsevier; 2017. pp. 141-57. [DOI: 10.1016/b978-0-12-804274-8.00010-2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Childers RE, Ahn J. Diagnosis of Alcoholic Liver Disease: Key Foundations and New Developments. Clin Liver Dis 2016;20:457-71. [PMID: 27373609 DOI: 10.1016/j.cld.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 de la M Hall P, Lieber CS, DeCarli LM, French SW, Lindros KO, Järveläinen H, Bode C, Parlesak A, Bode JC. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res. 2001;25:254S-261S. [PMID: 11391080 DOI: 10.1111/j.1530-0277.2001.tb02405.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
39 Jin J, Lee KB, Park SY, Jang JJ. Nicotinamide inhibits hepatic fibrosis by suppressing DNA synthesis and enhancing apoptosis of hepatic stellate cells. Virchows Arch 2011;458:689-96. [PMID: 21479726 DOI: 10.1007/s00428-011-1071-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
40 Neuman MG, Katz GG, Malkiewicz IM, Mathurin P, Tsukamoto H, Adachi M, Ishii H, Colell A, García-Ruiz C, Fernández-Checa JC, Casey CA. Alcoholic liver injury and apoptosis--synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism, Paris, September 16, 2001. Alcohol 2002;28:117-28. [PMID: 12457943 DOI: 10.1016/s0741-8329(02)00243-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
41 Xiang S, Lu L, Zhong H, Lu M, Mao H. SERS diagnosis of liver fibrosis in the early stage based on gold nanostar liver targeting tags. Biomater Sci 2021;9:5035-44. [PMID: 34110332 DOI: 10.1039/d1bm00013f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Lambert JC, Zhou Z, Kang YJ. Suppression of Fas-mediated signaling pathway is involved in zinc inhibition of ethanol-induced liver apoptosis. Exp Biol Med (Maywood) 2003;228:406-12. [PMID: 12671185 DOI: 10.1177/153537020322800411] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
43 Nanji AA, Zhao S, Sadrzadeh SM, Dannenberg AJ, Tahan SR, Waxman DJ. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol Clin Exp Res. 1994;18:1280-1285. [PMID: 7847620 DOI: 10.1111/j.1530-0277.1994.tb00119.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 177] [Article Influence: 7.2] [Reference Citation Analysis]
44 Nanji AA, Tahan SR, Wei Y, Sadrzadeh SM. Hepatic sinusoidal endothelial cell G1/S arrest correlates with severity of alcoholic liver injury in the rat. Gastroenterology 1994;107:818-23. [PMID: 7915700 DOI: 10.1016/0016-5085(94)90132-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
45 Medici V, Virata MC, Peerson JM, Stabler SP, French SW, Gregory JF, Albanese A, Bowlus CL, Devaraj S, Panacek EA, Richards JR, Halsted CH. S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial. Alcohol Clin Exp Res. 2011;35:1960-1965. [PMID: 22044287 DOI: 10.1111/j.1530-0277.2011.01547.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
46 Medici V, Shibata NM, Kharbanda KK, Islam MS, Keen CL, Kim K, Tillman B, French SW, Halsted CH, LaSalle JM. Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the tx-j mouse model of Wilson disease. Epigenetics. 2014;9:286-296. [PMID: 24220304 DOI: 10.4161/epi.27110] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
47 Kenner L, Zatloukal K, Stumptner C, Eferl R, Denk H. Altered microtubule-associated tau messenger RNA isoform expression in livers of griseofulvin- and 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated mice. Hepatology 1999;29:793-800. [DOI: 10.1002/hep.510290325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
48 Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, Adams DH. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998;186:82-9. [PMID: 9875144 DOI: 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D] [Cited by in Crossref: 95] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
49 Nanji AA, Greenberg SS, Tahan SR, Fogt F, Loscalzo J, Sadrzadeh SM, Xie J, Stamler JS. Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology. 1995;109:899-907. [PMID: 7657120 DOI: 10.1016/0016-5085(95)90400-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
50 Alpert L, Hart J. The Pathology of Alcoholic Liver Disease. Clinics in Liver Disease 2016;20:473-89. [DOI: 10.1016/j.cld.2016.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
51 Haydon G, Lalor PF, Hubscher SG, Adams DH. Lymphocyte recruitment to the liver in alcoholic liver disease. Alcohol. 2002;27:29-36. [PMID: 12062634 DOI: 10.1016/s0741-8329(02)00208-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
52 Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, Cadrin M, Omary MB. From Mallory to Mallory–Denk bodies: What, how and why? Experimental Cell Research 2007;313:2033-49. [DOI: 10.1016/j.yexcr.2007.04.024] [Cited by in Crossref: 230] [Cited by in F6Publishing: 211] [Article Influence: 15.3] [Reference Citation Analysis]
53 Bisgaard HC, Thorgeirsson SS. Hepatic Regeneration: The Role of Regeneration in Pathogenesis of Chronic Liver Diseases. Clinics in Laboratory Medicine 1996;16:325-39. [DOI: 10.1016/s0272-2712(18)30272-5] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
54 Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Alimentary Pharmacology & Therapeutics 2009;30:3-13. [DOI: 10.1111/j.1365-2036.2009.04002.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
55 Stumptner C, Omary MB, Fickert P, Denk H, Zatloukal K. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. Am J Pathol 2000;156:77-90. [PMID: 10623656 DOI: 10.1016/S0002-9440(10)64708-6] [Cited by in Crossref: 76] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
56 Mcphaul LW, Wang J, Hol EM, Sonnemans MA, Riley N, Nguyen V, Yuan QX, Lue Y, van Leeuwen FW, French SW. Molecular misreading of the ubiquitin B gene and hepatic mallory body formation. Gastroenterology 2002;122:1878-85. [DOI: 10.1053/gast.2002.33629] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
57 Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol. 2011;2011:345803. [PMID: 21197451 DOI: 10.1155/2011/3458033010664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216-254. [PMID: 24133661 DOI: 10.3350/cmh.2013.19.3.216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
59 Lefkowitch JH. Morphology of Alcoholic Liver Disease. Clinics in Liver Disease 2005;9:37-53. [DOI: 10.1016/j.cld.2004.11.001] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 7.5] [Reference Citation Analysis]
60 Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999;14:946-959. [PMID: 10530489 DOI: 10.1046/j.1440-1746.1999.01982.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 133] [Article Influence: 7.0] [Reference Citation Analysis]
61 Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clinics in Liver Disease 2002;6:399-420. [DOI: 10.1016/s1089-3261(02)00002-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
62 Cooksley W. Chronic liver disease: Do alcohol and hepatitis C virus interact? J Gastroenterol Hepatol 1996;11:187-92. [DOI: 10.1111/j.1440-1746.1996.tb00059.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
63 Medici V, Schroeder DI, Woods R, LaSalle JM, Geng Y, Shibata NM, Peerson J, Hodzic E, Dayal S, Tsukamoto H, Kharbanda KK, Tillman B, French SW, Halsted CH. Methylation and gene expression responses to ethanol feeding and betaine supplementation in the cystathionine beta synthase-deficient mouse. Alcohol Clin Exp Res 2014;38:1540-9. [PMID: 24730561 DOI: 10.1111/acer.12405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
64 Syn WK, Teaberry V, Choi SS, Diehl AM. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 2009;29:200-10. [PMID: 19387919 DOI: 10.1055/s-0029-1214375] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
65 Medici V, Peerson JM, Stabler SP, French SW, Gregory JF, Virata MC, Albanese A, Bowlus CL, Devaraj S, Panacek EA. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease. J Hepatol. 2010;53:551-557. [PMID: 20561703 DOI: 10.1016/j.jhep.2010.03.029] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
66 Zhuge J, Cederbaum AI. Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1. Free Radic Biol Med. 2006;40:63-74. [PMID: 16337880 DOI: 10.1016/j.freeradbiomed.2005.08.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
67 Zhou G, Zhao J, Ding X, Pan D, Sun Y, Yang J, Zhao Y. Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system. Front Med China 2007;1:413-7. [PMID: 24573937 DOI: 10.1007/s11684-007-0081-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Neuman MG, French SW, Casey CA, Kharbanda KK, Nanau RM, Rasineni K, Mcvicker BL, Kong V, Donohue TM. Changes in the pathogenesis of alcohol-induced liver disease — Preclinical studies. Experimental and Molecular Pathology 2013;95:376-84. [DOI: 10.1016/j.yexmp.2013.10.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
69 Willis MS, Klassen LW, Tuma DJ, Sorrell MF, Thiele GM. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res. 2002;26:94-106. [PMID: 11821659 DOI: 10.1111/j.1530-0277.2002.tb02436.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
70 Casey CA, Lee SM, Aziz-Seible R, McVicker BL. Impaired receptor-mediated endocytosis: its role in alcohol-induced apoptosis. J Gastroenterol Hepatol. 2008;23 Suppl 1:S46-S49. [PMID: 18336663 DOI: 10.1111/j.1440-1746.2007.05275.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
71 French SW, Vitocruz E, French BA. Balloon liver cells forming Mallory-Denk-bodies are progenitor cells. Exp Mol Pathol. 2013;95:117-120. [PMID: 23773849 DOI: 10.1016/j.yexmp.2013.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Zahr NM, Mayer D, Vinco S, Orduna J, Luong R, Sullivan EV, Pfefferbaum A. In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology 2009;34:1427-42. [PMID: 18704091 DOI: 10.1038/npp.2008.119] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
73 Huang YW, Yang SS, Kao JH. Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med 2011;3:1-11. [PMID: 24367215 DOI: 10.2147/HMER.S10265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
74 Amidi F, French BA, Chung D, Halsted CH, Medici V, French SW. M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. Exp Mol Pathol 2007;83:296-300. [PMID: 17963745 DOI: 10.1016/j.yexmp.2007.09.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
75 Bendtsen F, Dam-larsen S. Long-Term, Clinical Follow-Up in Fatty Liver Patients. Dig Dis 2010;28:709-14. [DOI: 10.1159/000324277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
76 Rust C, Gores GJ. Apoptosis and liver disease. Am J Med. 2000;108:567-574. [PMID: 10806286 DOI: 10.1016/s0002-9343(00)00370-3] [Cited by in Crossref: 137] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
77 Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20(33): 11684-11699 [PMID: 25206273 DOI: 10.3748/wjg.v20.i33.11684] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
78 Nanji AA, Khwaja S, Khettry U, Hossein Sadrzadeh S. Plasma endothelin levels in chronic ethanol fed rats: relationship to pathologic liver injury. Life Sciences 1994;54:423-8. [DOI: 10.1016/0024-3205(94)00700-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
79 de Pril R, Fischer DF, van Leeuwen FW. Conformational diseases: an umbrella for various neurological disorders with an impaired ubiquitin-proteasome system. Neurobiol Aging 2006;27:515-23. [PMID: 16226348 DOI: 10.1016/j.neurobiolaging.2005.04.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
80 Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV. Quantitative Study of the Variability of Hepatic Iron Concentrations. Clinical Chemistry 1999;45:340-6. [DOI: 10.1093/clinchem/45.3.340] [Cited by in Crossref: 94] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
81 French SW, Mayer RJ, Bardag-Gorce F, Ingelman-Sundberg M, Rouach H, Neve And E, Higashitsuji H. The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugs. Alcohol Clin Exp Res 2001;25:225S-9S. [PMID: 11391075 DOI: 10.1097/00000374-200105051-00036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
82 Cameron RG, Neuman MG. Novel morphologic findings in alcoholic liver disease. Clin Biochem 1999;32:579-84. [PMID: 10614721 DOI: 10.1016/s0009-9120(99)00058-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
83 Zahr NM, Mayer D, Rohlfing T, Hasak MP, Hsu O, Vinco S, Orduna J, Luong R, Sullivan EV, Pfefferbaum A. Brain injury and recovery following binge ethanol: evidence from in vivo magnetic resonance spectroscopy. Biol Psychiatry 2010;67:846-54. [PMID: 20044076 DOI: 10.1016/j.biopsych.2009.10.028] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
84 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492-510. [PMID: 25217800 DOI: 10.1016/j.yexmp.2014.09.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
85 Neuman MG, Monteiro M, Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 2006;41:1395-463. [PMID: 17002989 DOI: 10.1080/10826080600846235] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
86 Wang MX, Morgan T, Lungo W, Wang L, Sze GZ, French SW. "Piecemeal" necrosis: renamed troxis necrosis. Exp Mol Pathol 2001;71:137-46. [PMID: 11599920 DOI: 10.1006/exmp.2001.2397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
87 Brunt EM, Tiniakos DG. Pathology of steatohepatitis. Best Practice & Research Clinical Gastroenterology 2002;16:691-707. [DOI: 10.1053/bega.2002.0326] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
88 Tan HH, Virmani S, Martin P. Controversies in the management of alcoholic liver disease. Mt Sinai J Med. 2009;76:484-498. [PMID: 19787655 DOI: 10.1002/msj.20135] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]